Dave Muoio

By Dave Muoio 03:59 pmNovember 8, 2019
Virtual reality treatment startup AppliedVR announced a collaboration with the National Institutes of Health’s National Cancer Institute that aims to explore whether or not the immersive technology can reduce anxiety among patients with terminal cancer. The phase 1 study will enroll patients from the institute’s designated cancer centers, and could yield a follow-up phase 2 investigation...
By Dave Muoio 02:15 pmNovember 8, 2019
Data-driven smart bed maker Eight Sleep (formerly known as Luna) has raised $40 million in its latest investment round, announced Wednesday. The funding was headed by Founders Fund, and included support from Craft Ventures, Khosla Ventures, Y Combinator, 8VC, Flexport’s Ryan Petersen and Eventbrite’s Kevin Hartz. Alongside its prior rounds, this week’s news brings the company to a total raise of...
By Dave Muoio 03:50 pmNovember 7, 2019
AiCure, a nearly decade-old startup using artificial intelligence to measure medication adherence and other behavior during clinical trials or normal care, has brought in $24.5 million in Series C funding. Palisades Growth Capital led the raise, which also featured new backers Singtel Innov8, Asahi Kasei Corporation, Accelmed Growth Partners, and SpringRock Ventures. The round also included all...
By Dave Muoio 02:33 pmNovember 7, 2019
Fitbit’s year-over-year device sales flatlined in Q3 2019, which combined with lower sales tag prices drove a decline in revenue, according to the wearables maker’s latest quarterly earnings. The reporting — which was bereft of an investor’s call, Q&A and any forward-looking statements due to the company’s pending acquisition — is the latest look at a wearables business Google apparently...
By Dave Muoio 10:34 amNovember 7, 2019
Telehealth giant American Well has struck a deal to acquire Aligned Telehealth, a vendor of telepsychiatry and behavioral health that services providers and payers. American Well says that this move will make it the largest enterprise telepsychiatry platform operating in the US. At this time, the companies are not sharing any terms of the deal such as its price, official effective date or whether...
By Dave Muoio 03:59 pmNovember 6, 2019
Due to their increasingly personalized and convenient experiences with other sectors, consumers have high expectations when it comes to the services they’re receiving from the healthcare industry, according to a new global survey from Salesforce Research of nearly 6,000 consumers. Unfortunately, nearly half (47%) of those polled believe that the healthcare and life sciences are less focused on...
By Dave Muoio 11:20 amNovember 6, 2019
Boston-based PathAI, maker of artificial intelligence tools for pathology, has capped off its Series B funding round with a $15 million strategic investment from the Merck Global Health Innovation Fund and Bristol-Myers Squibb. This raise brings the startup’s full round to $75 million, and its total funding to just over $90 million. WHAT THEY DO PathAI’s platform employs convolutional neural...
By Dave Muoio 03:03 pmNovember 5, 2019
Friday marked the end of Dr. Ned Sharpless’ time as acting commissioner of the FDA, with President Donald Trump pointing to Dr. Stephen Hahn, currently the chief medical officer of MD Anderson Cancer Center, as his official appointment for the role on Friday. Assistant Secretary for health at HHS Dr. Brett Giroir will act as the agency’s new acting head. “With Dr. Sharpless at the helm, the FDA...
By Dave Muoio 02:41 pmNovember 5, 2019
Scanwell Health, maker of a smartphone-based platform for home urinary tract infection screening, has raised $3.5 million in seed funding. Founders Fund, Mayfield, DCM, Version One, Y Combinator and Liquid 2 Ventures all participated in the round. The startup paired this announcement with the reveal of a new partnership with telehealth service Lemonaid Health that will bring its UTI platform to...
By Dave Muoio 12:00 pmNovember 5, 2019
Type 1 diabetes management and CGM integration are now on the table for WellDoc’s BlueStar, a management platform well known for being the first mobile health product to secure reimbursement as a diabetes therapy. Thanks to a new FDA clearance, the company’s seventh, BlueStar will include integrated glucose level insights related to food, medication and activity that are based on the data from...